Reporting recommendations for tumor marker prognostic studies (REMARK).

Reporting recommendations for tumor marker prognostic studies (REMARK).

Show other versions (4)

Despite years of research and hundreds of reports on tumor markers in oncology, the number of markers that have emerged as clinically useful is pitifully small. Often, initially reported studies of a marker show great promise, but subsequent studies on the same or related markers yield inconsistent...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	McShane, L, Altman, D, Sauerbrei, W, Taube, SE, Gion, M, Clark, G
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2005

Eitemau Tebyg

REporting recommendations for tumor MARKer prognostic studies (REMARK).
gan: McShane, L, et al.
Cyhoeddwyd: (2005)

REporting recommendations for tumor MARKer prognostic studies (REMARK).
gan: McShane, L, et al.
Cyhoeddwyd: (2006)

REporting recommendations for tumor MARKer prognostic studies (REMARK)
gan: McShane, L, et al.
Cyhoeddwyd: (2005)

REporting recommendations for tumor MARKer prognostic studies (REMARK)
gan: McShane, L, et al.
Cyhoeddwyd: (2005)

Re: Reporting recommendations for tumor marker prognostic studies (REMARK) - Reply
gan: McShane, L, et al.
Cyhoeddwyd: (2005)

REporting recommendations for tumour MARKer prognostic studies (REMARK).
gan: McShane, L, et al.
Cyhoeddwyd: (2005)

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.
gan: Altman, D, et al.
Cyhoeddwyd: (2012)

Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.
gan: Altman, D, et al.
Cyhoeddwyd: (2012)

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.
gan: Altman, D, et al.
Cyhoeddwyd: (2012)

Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.
gan: Altman, D, et al.
Cyhoeddwyd: (2012)

Reporting recommendations for tumor marker prognostic studies.
gan: McShane, L, et al.
Cyhoeddwyd: (2005)

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An abridged explanation and elaboration
gan: Sauerbrei, W, et al.
Cyhoeddwyd: (2018)

Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
gan: Altman Douglas G, et al.
Cyhoeddwyd: (2012-05-01)

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.
gan: Douglas G Altman, et al.
Cyhoeddwyd: (2012-01-01)

Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
gan: Mallett, S, et al.
Cyhoeddwyd: (2010)

Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines.
gan: Mallett, S, et al.
Cyhoeddwyd: (2010)

Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles
gan: Sekula, P, et al.
Cyhoeddwyd: (2017)

Identification of clinically useful cancer prognostic factors: what are we missing?
gan: McShane, L, et al.
Cyhoeddwyd: (2005)

Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles.
gan: Peggy Sekula, et al.
Cyhoeddwyd: (2017-01-01)

Importance of the distinction between quality of methodology and quality of reporting
gan: Altman, D, et al.
Cyhoeddwyd: (2017)

Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond.
gan: Riley, R, et al.
Cyhoeddwyd: (2009)

Evidence-based assessment and application of prognostic markers: The long way from single studies to meta-analysis
gan: Sauerbrei, W, et al.
Cyhoeddwyd: (2006)

[Diagnostic (STARD) and prognostic (REMARK) studies].
gan: Altman, D, et al.
Cyhoeddwyd: (2005)

Structured reporting to improve transparency of analyses in prognostic marker studies
gan: Willi Sauerbrei, et al.
Cyhoeddwyd: (2022-05-01)

Statistical challenges in the development and evaluation of marker-based clinical tests
gan: McShane Lisa M
Cyhoeddwyd: (2012-05-01)

Primer: an evidence-based approach to prognostic markers.
gan: Altman, D, et al.
Cyhoeddwyd: (2005)

Recommendations for use of tumor markers in monoclonal gammopathies
gan: Dajak Marijana
Cyhoeddwyd: (2007-01-01)

Overinterpretation and misreporting of prognostic factor studies in medical oncology
gan: Kempf, E, et al.
Cyhoeddwyd: (2016)

Explicit inclusion of treatment in prognostic modelling was recommended in observational and randomised settings
gan: Groenwold, R, et al.
Cyhoeddwyd: (2016)

Treatment Outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal Tumors.
gan: Seo Hee Choi, et al.
Cyhoeddwyd: (2016-01-01)

The prognostic value of tumor markers doubling times in medullary thyroid carcinoma - preliminary report
gan: Gawlik Tomasz, et al.
Cyhoeddwyd: (2010-11-01)

Dichotomizing continuous predictors in multiple regression: a bad idea.
gan: Royston, P, et al.
Cyhoeddwyd: (2006)

Modeling the effects of continuous risk factors.
gan: Royston, P, et al.
Cyhoeddwyd: (2000)

Serum Tumor Markers in Paraneoplastic Neurologic Syndromes: A Systematic Review of Guidelines
gan: Chiara Trevisiol, et al.
Cyhoeddwyd: (2021-01-01)

Early foreign language teaching: some critical remarks and some recommendations
gan: Annick De Houwer
Cyhoeddwyd: (2014-03-01)

Expression profiling of archival renal tumors by quantitative PCR to validate prognostic markers
gan: Sean T. Glenn, et al.
Cyhoeddwyd: (2007-11-01)

The prognostic value of postoperative tumor marker conversion for gastric cancer
gan: Jeongju Noh, et al.
Cyhoeddwyd: (2020-12-01)

Prognostic significance of tumor markers in T4a gastric cancer
gan: Liu Xiaowen, et al.
Cyhoeddwyd: (2012-04-01)

Prognostic markers of canine pyometra
gan: M.C. Sant'Anna, et al.
Cyhoeddwyd: (2014-12-01)

Diagnostic tests for Alzheimer's disease: Rationale, methodology, and challenges
gan: Ritchie, C, et al.
Cyhoeddwyd: (2010)